| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.9M | -17.5% | -57.6% |
| SG&A Expense | $1.6M | -21.2% | -10.4% |
| Operating Income | -$3.5M | +19.2% | +44.5% |
| Pre-tax Income | -$3.4M | +15.5% | +40.3% |
| Income Tax | $0 | — | — |
| Net Income | -$3.4M | +15.5% | +40.3% |
| EPS (Basic) | -$0.14 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.3M | -18.8% | -34.1% |
| Current Assets | $14.6M | -20.0% | -33.2% |
| Total Assets | $14.8M | -20.0% | -33.3% |
| Current Liabilities | $8.4M | -4.4% | -7.5% |
| Total Liabilities | $8.4M | -4.5% | -8.3% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.8M | — | — |
| Capital Expenditures | $2K | — | — |
| Investing Cash Flow | -$2K | — | — |
| Financing Cash Flow | $9.1M | — | — |
| Free Cash Flow | -$10.8M | — | — |
| +74.5% |
| EPS (Diluted) | -$0.14 | +46.2% | +74.5% |
| $6.3M |
| -34.2% |
| -51.1% |